MDCO Medicines Co.

--- - 'The company recently received some great news about its cholesterol drug.Novartis(NYSE: NVS) has produced some uninspiring results on the markets. In five years, its share price has risen by just 8% while theHealth Care Select Sector SPDR Fund has grown 50%. But that could change in 2020 and the ...'

--- - First Midwest Bank Trust Division cut its stake in The Medicines Company (NASDAQ:MDCO) by 50.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,500 shares of the companys stock after selling 3,500 ...

--- - Verrica Pharmaceuticals (NASDAQ:VRCA) and The Medicines (NASDAQ:MDCO) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and...

--- - The Medicines Company (the Company) today provided notice of a Make-Whole Fundamental Change to holders of its (i) 2.50% Convertible Senior Notes due 2022 (the 2022 Notes), (ii) 2.75% Convertible Senior Notes due 2023 (the 2023 Notes) and (ii) 3.50% Convertible Senior Notes due 2024 (the 2024 Notes...

--- - 'Basel, January 6, 2020 Novartis AG (NYSE: NVS) (Novartis) today announced the successful completion of the previously announced tender offer by its indirect wholly-owned subsidiary, Medusa Merger Corporation (Purchaser), for all of the outstanding shares of common stock, par value USD 0.001 per ...'

--- - The Medicines Company (NASDAQ:MDCO) has been given a consensus rating of Hold by the seventeen analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and eight have ...